Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suraxavir Marboxil in Uncomplicated Acute Influenza
NCT04736758Phase 2Completed
- Sponsor
- Jiangxi Qingfeng Pharmaceutical Co. Ltd.
- Start
- Jan 2021
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of suraxavir marboxil in influenza, sponsored by Jiangxi Qingfeng Pharmaceutical Co. Ltd.. Started Jan 2021; status: completed.
02
Drugs
suraxavir marboxil
03
Conditions
influenza
Beyond the preview
Go deeper on NCT04736758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04736758.